Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
1990-11-27 to 1990-12-06
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1990
Report date:
1990

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
1983
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
2,2'-[oxybis(2,1-ethanediyloxy)]bisacetic acid
EC Number:
237-655-9
EC Name:
2,2'-[oxybis(2,1-ethanediyloxy)]bisacetic acid
Cas Number:
13887-98-4
Molecular formula:
C8H14O7
IUPAC Name:
2-{2-[2-(carboxymethoxy)ethoxy]ethoxy}acetic acid
Test material form:
other: liquid: clear colourless
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: D 269
- Expiration date of the lot/batch: stable until December 1991
- Purity test date: 1990-07-16

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: dark at approximately 5 °C
- Stability under test conditions: stable until December 1991, stability in solvent proved for 4 hours


Method

Target gene:
The Salmonella typhimurium histidine (his) reversion system measures his- → his+ reversions. The Salmonella typhimurium strains are constructed to differentiate between base pair (TA1535, TA100) and frameshift (TA1537, TA98) mutations.
Species / strain
Species / strain / cell type:
other: S. typhimurium TA 98, TA 100, TA 1535, TA 1537, TA 1538
Metabolic activation:
with and without
Metabolic activation system:
rat liver S9 mix, Aroclor 1254 induced
Test concentrations with justification for top dose:
The test compound was tested at doses of 4 to 10000 microgram/plate and proved to be toxic to the bacterial strains at doses of 2500 microgram/ plate. Thinning of the bacterial lawn and a reduction in the number of colonies have been observed at this dose.
Concentrations: 0, 4, 20, 100, 500, 2500, 5000, 10000 µg/plate
Vehicle / solvent:
- Vehicle/solvent used: water
- Justification for choice of solvent/vehicle: soluble in water
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
Remarks:
without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
2-nitrofluorene
Remarks:
without metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
benzo(a)pyrene
Remarks:
with metabolic activation
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2- aminoanthracene
Remarks:
with metabolic activation
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)

DURATION
- Exposure duration: 48 h

SELECTION AGENT: histidine

NUMBER OF REPLICATIONS: 3

NUMBER OF CELLS EVALUATED: all revertant colonies were counted


DETERMINATION OF CYTOTOXICITY
- Method: relative total growth


Rationale for test conditions:
standard test conditions for this assay
Evaluation criteria:
A test article is classified mutagenic if either of the following conditions under a) and b) is achieved:
a) a test article produces at least a 2-fold increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control at complete bacterial background lawn
b) a test article induces a dose-related increase in the mean number of revertants per plate of at least one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control in at least two to three concentrations of the test article at complete bacterial background lawn.
The test results must be reproducible.
Statistics:
Statistical analysis is not neccessary as only the number of colonies has to be compared to the controls.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxicity observed at doses of 2500 µg/plate onwards
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
Cytotoxicity was observed in the preliminary experiment at doses of 2500 µg/plate and above.
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxicity observed at doses of 2500 µg/plate onwards
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxicity observed at doses of 2500 µg/plate onwards
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1538
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
cytotoxicity observed at doses of 2500 µg/plate onwards
Vehicle controls validity:
valid
Untreated negative controls validity:
not applicable
Positive controls validity:
valid

Any other information on results incl. tables

Table 1: Number of revertants per plate (mean of three plates), Experiment 1

strain

TA 100

strain

TA 1535

Strain

TA 1537

strain

TA 1538

strain

TA 98

conc. [µg] per plate

-MA

+MA

-MA

+MA

-MA

+MA

-MA

+MA

-MA

+MA

0

171

169

10

9

5

5

12

14

19

28

4

158

161

8

9

4

4

13

19

14

27

20

163

170

9

11

5

7

13

10

19

26

100

158

166

10

9

6

8

15

14

18

23

500

158

163

7

9

6

10

11

10

20

24

2500

140

144

9

12

8

6

14

15

15

25

10000

123

153

8

9

12

6

8

12

21

25

Sodium azide

1 µg

558

 

434

 

 

 

 

 

 

 

9-Aminoacridine

50 µg

 

 

 

 

282

 

 

 

 

 

2-Nitrofluorene

2.5 µg

 

 

 

 

 

 

1234

 

1019

 

2-Aminoanthracene

0.5 µg (TA 100, TA1538, TA98)

1µg (TA1535, TA1537)

 

725

 

178

 

124

 

474

 

484

Benzo[a]pyrene 10 µg

 

1316

 

35

 

128

 

202

 

588

 

 

Table 2: Number of revertants per plate (mean of three plates), Experiment 2

strain

TA 100

strain

TA 1535

Strain

TA 1537

strain

TA 1538

strain

TA 98

conc. [µg]

-MA

+MA

-MA

+MA

-MA

+MA

-MA

+MA

-MA

+MA

0

111

124

9

9

8

10

16

19

18

25

4

105

124

6

11

11

13

13

21

20

27

20

99

124

8

8

8

9

12

24

25

25

100

116

124

10

9

9

7

14

20

22

28

500

115

124

10

8

7

12

10

22

21

22

2500

113

105

6

12

7

6

11

25

28

18

10000

105

100

7

8

7

7

17

20

24

23

Sodium azide

1 µg

494

 

375

 

 

 

 

 

 

 

9-Aminoacridine

50 µg

 

 

 

 

246

 

 

 

 

 

2-Nitrofluorene

2.5 µg

 

 

 

 

 

 

874

 

652

 

2-Aminoanthracene

0.5 µg (TA 100, TA1538, TA98)

1µg (TA1535, TA1537)

 

570

 

130

 

121

 

323

 

347

Benzo[a]pyrene 10 µg

 

1198

 

18

 

126

 

131

 

616

Applicant's summary and conclusion

Conclusions:
The test substance was not mutagenic in this bacterial reverse mutation assay.
Executive summary:

The test item was tested for mutagenicity with the strains TA 100, TA 1535, TA 1537, TA 1538, TA 98 of Salmonella typhimurium.

The mutagenicity studies were conducted in the absence and in the presence of a metabolizing system derived from rat liver homogenate (S9 mix, Aroclor 1254 induced). A dose range of 6 different doses from 4 microgram/plate to 10000 microgram/plate was used.

Control plates without mutagen showed that the number of spontaneous revertant colonies was similiar to that described in the literature. All the positive control compounds gave the expected increase in the number of revertant colonies. The test compound proved to be toxic to the bacterial strains at 2500 microgram/plate. In the absence of the metabolic activation system the test compound did not show a dose dependent increase in the number of revertants in any of the bacterial strains. Also in the presence of a metabolic activation system, treatment of the cells with the test item did not result in relevant increases in the number of revertant colonies. Summarizing, it can be stated that the test item is not mutagenic in these bacterial test systems either with or without exogenous metabolic activation at the dose levels investigated.